Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer Article (Web of Science)

International Collaboration

cited authors

  • Oshi, Masanori; Ghasemi, Farhad; Yamada, Akimitsu; Yan, Li; Zhang, Jianmin; Abrams, Scott I.; Endo, Itaru; Takabe, Kazuaki

publication date

  • June 21, 2025

webpage

published in

category

keywords

  • Biomarker
  • Breast cancer
  • Gene expression
  • HER2
  • Hippo pathway
  • Survival
  • Treatment response

start page

  • 7959

end page

  • 7969

volume

  • 32

issue

  • 10